Related Experiment Video
Updated: Aug 2, 2025

Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
Normal range and predictors of serum erythroferrone in infants
Fredrik Bäckström1, Anna Chmielewska1, Magnus Domellöf1
1Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
Insights
Erythroferrone (ERFE) levels in infants are established for the first time, showing low concentrations at birth that increase over the first year. Infant ERFE levels do not correlate with iron status, suggesting different iron regulation compared to adults.
Area of Science:
- Pediatric Hematology
- Iron Metabolism
- Endocrinology
Background:
- Erythroferrone (ERFE) is a hepcidin-regulating hormone linked to erythropoiesis and iron needs in adults.
- Its role and concentration patterns in infants are not well understood.
Purpose of the Study:
- To determine serum concentrations of ERFE in healthy infants during their first year of life.
- To identify predictors of ERFE levels, including birth weight and iron supplementation.
Main Methods:
- ERFE levels were measured in 45 normal birth weight (NBW) and 136 marginally low birth weight (LBW) infants at four time points from 6 weeks to 12 months.
- LBW infants received either iron supplementation or placebo between 6 weeks and 6 months.
Main Results:
- ERFE concentrations were low at birth, rising throughout the first year, with established reference ranges for NBW infants.
- LBW infants had higher ERFE at 6 weeks but lower at 12 months compared to NBW infants; iron supplementation had minimal effect.
- Correlations between ERFE and erythropoietic or iron status markers were weak and inconsistent in infants.
Conclusions:
- This study provides the first normal ranges for erythroferrone in healthy infants.
- ERFE in infants appears to be dissociated from iron status and erythropoiesis markers, unlike in adults.
- Findings suggest distinct infant iron homeostasis regulation and highlight the need for infant-specific studies, potentially impacting anemia management.
Background:
Erythroferrone (ERFE) has been identified as a hepcidin-regulating hormone synthetized by erythroblasts correlating to the erythropoietic activity and the needs for iron substrate in bone marrow of adults. The present study aimed to assess the ERFE serum concentrations and its predictors in infants.
Methods:
ERFE was explored at 4 time points during the first year of life in 45 healthy, breastfed, normal birth weight (NBW) infants, and 136 marginally low birth weight infants (LBW, 2000-2500 g) receiving iron (N = 58) or placebo (N = 78) between 6 weeks and 6 months of age.
Results:
ERFE concentrations were low at birth, increasing gradually during the first year of life. In NBW infants, reference ranges (5th to 95th percentile) were at 6 weeks <0.005-0.99 ng/mL and at 12 months <0.005-33.7 ng/mL. ERFE was higher in LBW infants at 6 weeks but lower at 12 months compared to NBW and minimally affected by iron supplementation among LBW infants. Correlations of ERFE with erythropoietic and iron status markers were weak and inconsistent.
Conclusions:
The role of ERFE in the crosstalk of erythropoiesis and iron homeostasis remains unclear in infants and further studies on ERFE in infants and older children are warranted within the framework of the erythropoietin-ERFE-hepcidin axis.
Impact:
Normal range of erythroferrone in healthy infants is described for the first time. Erythroferrone in infants lacks correlation to iron status and markers of erythropoiesis. The findings indicate differences in infant regulation of iron homeostasis as compared to adults. The findings point to a need to study infant erythropoiesis separately from its adult counterpart. The findings may have clinical impact on management strategies of iron-loading anemia in infancy.
Related Concept Videos
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Erythropoiesis
Serum Studies: Renal Function Tests
The Early Endosome: Endocytosis of Transferrin
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Lifecycle of Erythrocytes
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....

